GenoMe Diagnostics Preparing Digital PCR-Based Ovarian Cancer Test for US, EU, UK Submissions
The Belfast, Northern Ireland-based company also believes its technology could be used to create other early-stage detection tests for multiple cancers.
Northern Ireland-Based Cancer Dx Firm GenoMe Diagnostics Raises £1.4M
The Queen's University Belfast spinout plans to develop a blood test called OvaMe for the early detection of ovarian cancer.
Bio-Rad Q4 Revenues Flat, Miss Analyst Estimates
The firm also said it is carrying excess inventory needed to assemble instruments and components that it acquired to fend off supply chain issues.
The assay combines microfluidics, gene expression, and digital PCR to provide information on whether a patient's cancer has metastasized.
Qiagen Cites Competitive Advantages in Digital PCR, Sequencing Assays as Part of Core Growth Plan
On a call with investors to discuss third quarter results, the firm also offered updates on its syndromic testing and NeuMoDx businesses.